Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
3SBio
Asia
Sinopharm, Sinovac, Takeda and more—FiercePharmaAsia
Two China-made inactivated COVID-19 vaccines report positive clinical data. Takeda sells seven programs to Neurocine.
Angus Liu
Jun 19, 2020 10:44am
AstraZeneca, Pfizer Japan and more—FiercePharmaAsia
Feb 15, 2019 10:53am
FiercePharmaAsia—China's landmark nod, Samsung, WuXi and more
May 4, 2018 9:56am
FiercePharmaAsia—Eli Lilly, OrbiMed, Takeda
Sep 8, 2017 8:13am
China’s 3SBio JV seeks to buy Canadian CDMO Therapure for $290M
Sep 7, 2017 9:38am
AZ taps 3SBio to help drive sales of Byetta, Bydureon in China
Oct 13, 2016 9:49am
